MetaADEDB 2.0 @ LMMD
Butylscopolammonium Bromide
(HOZOZZFCZRXYEK-HNHWXVNLSA-M)
Structure
SMILES
CCCC[N+]1(C)[C@@H]2CC(C[C@H]1[C@H]1[C@@H]2O1)OC(=O)[C@@H](c1ccccc1)CO.[Br-]
Molecular Formula:
C21H30BrNO4
Molecular Weight:
440.371
Log P:
-0.8042
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
59.06
CAS Number(s):
149-64-4
Synonym(s)
1.
Butylscopolammonium Bromide
2.
Hyoscinbutylbromide
3.
Scopolaminebutylbromide
4.
Buscapine
5.
Buscolysin
6.
Buscopan
7.
Butylscopolamine
8.
Hyoscine N-Butylbromide
9.
N-Butylscopolammonium Bromide
10.
Scopolan
11.
Bromide, Butylscopolammonium
12.
Bromide, N-Butylscopolammonium
13.
Hyoscine N Butylbromide
14.
N Butylscopolammonium Bromide
15.
N-Butylbromide, Hyoscine
External Link(s)
MeSHD002086
PubChem Compound6852391
ChEBI32123
CHEMBLCHEMBL1256901
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AmnesiaCanada Vigilance: 2Canada Vigilance
2Anaphylactic shockCanada Vigilance: 1Canada Vigilance
3Angioedema7111123CTD
4Blood creatine phosphokinase increasedCanada Vigilance: 1Canada Vigilance
5BradycardiaCanada Vigilance: 2Canada Vigilance
6Drug Eruptions11792017CTD
7Gastrointestinal PainCanada Vigilance: 1Canada Vigilance
8Pain17465473CTD
9PalpitationsCanada Vigilance: 1Canada Vigilance
10SneezingCanada Vigilance: 1Canada Vigilance
11TachycardiaCanada Vigilance: 1Canada Vigilance
12Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
13Urticaria7111123
11792017
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.